Holen Sie sich die Stockscreener-App
33.67
0.36%
0.12
Handel nachbörslich:
32.80
-0.87
-2.58%
Schlusskurs vom Vortag:
$33.55
Offen:
$33.42
24-Stunden-Volumen:
1.13M
Relative Volume:
2.06
Marktkapitalisierung:
$1.70B
Einnahmen:
$226.84M
Nettoeinkommen (Verlust:
$3.55M
KGV:
481.00
EPS:
0.07
Netto-Cashflow:
$-12.02M
1W Leistung:
-6.19%
1M Leistung:
-10.40%
6M Leistung:
-34.16%
1J Leistung:
-29.81%
1-Tages-Spanne:
$33.36
$34.56
1-Wochen-Bereich:
$33.34
$36.81
52-Wochen-Spanne:
$33.09
$63.00
Vericel Corp Stock (VCEL) Company Profile
Firmenname
Vericel Corp
Sektor
Branche
Telefon
(734) 930-5555
Adresse
64 SIDNEY ST., CAMBRIDGE, MA
Vergleichen Sie VCEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
33.67 | 1.75B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-06-20 | Eingeleitet | TD Cowen | Buy |
| 2024-01-25 | Hochstufung | Truist | Hold → Buy |
| 2023-08-08 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-11-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-11-09 | Herabstufung | Truist | Buy → Hold |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2021-01-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Eingeleitet | Stephens | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2019-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Needham | Buy → Hold |
| 2018-08-08 | Bestätigt | Needham | Buy |
| 2018-07-16 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | Eingeleitet | Leerink Partners | Outperform |
| 2018-03-06 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | Bestätigt | Needham | Buy |
| 2018-03-05 | Bestätigt | BTIG Research | Buy |
| 2017-06-21 | Eingeleitet | BTIG Research | Buy |
| 2017-03-13 | Bestätigt | Needham | Buy |
| 2016-12-22 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-09 | Bestätigt | Needham | Buy |
| 2016-04-05 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Vericel Corp Aktie (VCEL) Neueste Nachrichten
Vericel at Wells Fargo Conference: Strategic Growth and Expansion - Investing.com
Pattern recognition hints at Vericel Corporation upsidePortfolio Risk Report & Real-Time Market Trend Scan - Newser
What machine learning models say about Vericel CorporationTrade Analysis Summary & Capital Efficiency Focused Strategies - Newser
What earnings revisions data tells us about Vericel CorporationJuly 2025 EndofMonth & Risk Controlled Stock Alerts - Newser
Will Vericel Corporation benefit from current market trendsTrade Volume Summary & Low Drawdown Investment Strategies - khodrobank.com
Will Vericel Corporation bounce back from current supportEarnings Recap Summary & Growth-Oriented Investment Plans - Newser
Is Vericel Corporation stock bottoming outJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - Newser
Vericel Corp's CMO buys and sells shares on Sept 2. - AInvest
Using Python tools to backtest Vericel Corporation strategiesGap Down & Comprehensive Market Scan Insights - Newser
Can a trend reversal in Vericel Corporation lead to recoveryMarket Activity Report & Real-Time Market Trend Scan - Newser
Will a bounce in Vericel Corporation offer an exitPortfolio Value Report & Intraday High Probability Setup Alerts - Newser
Is this a good reentry point in Vericel CorporationPortfolio Value Report & Stepwise Trade Execution Plans - Newser
Has Vericel Corporation formed a bullish divergenceJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser
Will Vericel Corporation continue its uptrendGlobal Markets & Low Risk High Reward Trade Ideas - Newser
What is Vericel Corporation s P E ratio telling usPortfolio Growth Summary & Weekly Watchlist of Top Performers - khodrobank.com
Backtesting results for Vericel Corporation trading strategiesWatch List & Verified Momentum Stock Alerts - Newser
Is Vericel Corporation stock technically oversoldWeekly Market Outlook & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Northern Trust Corp Sells 1,550 Shares of Vericel Corporation $VCEL - Defense World
Is Vericel Corporation stock ready for a breakout2025 Market Trends & Long Hold Capital Preservation Plans - Newser
What MACD and RSI say about Vericel Corporation2025 Institutional Moves & Verified Swing Trading Watchlists - Newser
Using data tools to time your Vericel Corporation exitMarket Performance Report & Daily Market Momentum Tracking - Newser
Analyzing Vericel Corporation with risk reward ratio chartsLong Setup & Real-Time Stock Entry Alerts - Newser
Is Vericel Corporation forming a bottoming base2025 Breakouts & Breakdowns & Precise Buy Zone Tips - Newser
Using fundamentals and technicals on Vericel CorporationJobs Report & AI Driven Stock Reports - Newser
Statistical indicators supporting Vericel Corporation’s strength2025 Market Overview & Precise Buy Zone Tips - Newser
Volume Profile Shows Strong Base for Vericel Corporation2025 Winners & Losers & Community Shared Stock Ideas - beatles.ru
Published on: 2025-08-29 21:25:24 - Newser
Live market analysis of Vericel CorporationMarket Risk Analysis & Accurate Entry and Exit Point Alerts - Newser
Published on: 2025-08-29 18:53:20 - Newser
Institutional Tools Highlight Unusual Flow in Vericel Corporation getLinesFromResByArray error: size == 0 - sisain.net
Finanzdaten der Vericel Corp-Aktie (VCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Vericel Corp-Aktie (VCEL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark | Chief Medical Officer |
Sep 02 '25 |
Sale |
35.77 |
10,000 |
357,700 |
66,363 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):